Recommendation for treatment of hepatitis C virus infection
Turk J Gastroenterol
.
2017 Dec;28(Suppl 2):94-100.
doi: 10.5152/tjg.2017.22.
Authors
Sabahattin Kaymakoğlu
1
,
İftihar Köksal
1
,
Fehmi Tabak
1
,
Ulus S Akarca
1
,
Ayhan Akbulut
1
,
Filiz Akyüz
1
,
Hürrem Bodur
1
,
Atahan Çağatay
1
,
Dinç Dinçer
1
,
Şaban Esen
1
,
Rahmet Güner
1
,
Selim Gürel
1
,
Şükran Köse
1
,
Ömer Şentürk
1
,
Halis Şimşek
1
,
Tansu Yamazhan
1
,
Yusuf Yılmaz
1
,
Ramazan Idilman
1
,
Viral Hepatitis Guidelines Study Group
2
Affiliations
1
Turkish Association for the Study of the Liver, İstanbul, Turkey; Viral Hepatitis Society, Ankara, Turkey.
2
Viral Hepatitis Guidelines Study Group.
PMID:
29303106
DOI:
10.5152/tjg.2017.22
No abstract available
Publication types
Practice Guideline
MeSH terms
Antiviral Agents / therapeutic use*
Genotype
Hepacivirus / genetics
Hepatitis C / complications
Hepatitis C / drug therapy*
Humans
Liver Cirrhosis / drug therapy*
Liver Cirrhosis / virology
Turkey
Substances
Antiviral Agents